SCHEMBL880353

SCHEMBL880353

COc1ccc2c(c1)NC(=O)CC2c1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.63
MEN1 O00255 1/20 0.63
NPC1 O15118 1/20 0.63
TDP1 Q9NUW8 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
PKM P14618 1/20 0.56
TSHR P16473 2/20 0.54
GAA P10253 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.53
TP53 P04637 1/20 0.52
ALDH1A1 P00352 1/20 0.51
MAPK1 P28482 1/20 0.51
LMNA P02545 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL880263 0.89 KMT2A (0.60) KMT2AMEN1NPC1TDP1L3MBTL1
SCHEMBL30866425 0.89 KMT2A (0.60) KMT2AMEN1NPC1TDP1L3MBTL1
SCHEMBL880441 0.85 MEN1 (0.69) KMT2AMEN1NPC1TDP1L3MBTL1
SCHEMBL10090757 0.82 GAA (0.78) KMT2ATDP1L3MBTL1PKMTSHR
SCHEMBL12470042 0.81 GAA (0.56) KMT2AMEN1NPC1TDP1L3MBTL1
SCHEMBL880352 0.81 KMT2A (0.73) KMT2AMEN1NPC1TDP1L3MBTL1
SCHEMBL880446 0.79 KMT2A (0.48) KMT2AMEN1NPC1TDP1L3MBTL1
SCHEMBL1038757 0.79 SMN1; SMN2 (0.52) KMT2AMEN1NPC1TDP1L3MBTL1
SCHEMBL880376 0.78 ALDH1A1 (0.58) KMT2AMEN1NPC1TDP1L3MBTL1
SCHEMBL7156373 0.78 ALDH1A1 (0.58) KMT2AMEN1NPC1TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8440705-B2 2,3,4,7,8,9-hexahydro-1H-cyclopenta[h]quinolin-2-one or 2,3,4,6,7,8-hexahydro-1H-cyclopenta[g]quinolin-2-one; Alzheimer's disease WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2013-05-14 US disclosed
EP-2433634-A2 Compounds, compositions and methods of inhibiting a-synuclein toxicity The Whitehead Institute for Biomedical Research (US) 2012-03-28 EP disclosed